oncaspar
servier laboratories nz ltd - pegaspargase 3750 u (4050u including overage) - powder for injection - 3750 u/5ml - active: pegaspargase 3750 u (4050u including overage) excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate sodium chloride sodium hydroxide sucrose - oncaspar is indicated as a component of antineoplastic combination therapy in patients with acute lymphoblastic leukaemia (all).
oncaspar solution
servier canada inc - pegaspargase - solution - 750unit - pegaspargase 750unit - antineoplastic agents
oncaspar powder for solution for injectioninfusion 750 uml
servier (s) pte ltd - pegaspargase - injection, powder, lyophilized, for solution - pegaspargase 750 u/ml
oncaspar liquid
aventis pharma inc - pegaspargase - liquid - 750unit - pegaspargase 750unit - antineoplastic agents
oncaspar
les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,
oncaspar 3,750units5ml solution for injection vials
imported (united states - pegaspargase - solution for injection - 750unit/1ml
oncaspar lyophilizate for solution for i/m injection and infusion
les laboratoires servier industrie 905 - pegaspargase - lyophilizate for solution for i/m injection and infusion - 750iu/ml
oncaspar 750 u/ml powder for solution for injection/ infusion (iv/im)
les laboratoires servier; importer: servier philippines, inc.; distributor: zuellig pharma corporation - pegaspargase - powder for solution for injection/ infusion (iv/im) - 750 u/ml
oncaspar powder for solution for injection/infusion
les laboratoires servier, france - pegaspargase - powder for solution for injection/infusion - 750 iu/ml,
oncaspar i.v. infusion (オンキャスパー点滴静注用3750)
nihon servier co. ltd., - pegaspargase - injection